Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial.

Diabetes Care · 2021 · PMC8323180 · PMID 34021020

Europe PMC DOI

hedged sentence

0.0523

closest p · 1.0× alpha

0.0523

boldest claim

The sentences

near-significantP = 0.0523so close (0.05 < p ≤ 0.1)

Significant differences were observed between active and placebo treatment groups in the prespecified subgroup defined by HLA DR3-DQ2 for HbA 1c ( P = 0.0100) and IDAA 1c ( P = 0.0101); a near-significant difference was seen for C-peptide AUC ( P = 0.0523).

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.